AOA Health Policy Institute's Response to COVID-19
The AOA Health Policy Institute (HPI) is closely monitoring developments and will actively provide updates regarding COVID-19 to ensure doctors of optometry and the public not only understand the risks associated with this pandemic but also have the latest information for continued patient care.
The AOA's and AOA HPI's priority is to support the health and safety of the public and the optometric community, and will continue to assess the situation and update recommendations accordingly.
We all see patients with mild vision loss who say their vision does not allow them to read the way they once could. Consider these strategies when refraction doesn’t yield a vision improvement and further disease treatment isn’t warranted.
Texas becomes the latest state to achieve a significant scope expansion in 2021, earning doctors’ authority to prescribe oral eye medications and independently manage glaucoma.
A new study reports partial recovery of visual function in a patient with late-stage retinitis pigmentosa using optogenetic therapy, a first for researchers looking into the neurodegenerative disease.